MedPath

Salmetide

Brand Name: Salmetide

Generic Name: Salmeterol (as xinafoate) + Fluticasone propionate

Active
Registration Number

DR-XY43066

Dosage Form

Dry Powder for Inhalation

Issuance Date

January 31, 2019

Expiry Date

December 9, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mcg/500 mcg
PackagingAlu/Alu Blister Pack x 8's (Box of 40's) with Inhaler

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Beta-2 Adrenoceptor Agonist/ Corticosteroid
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Salmeterol (as xinafoate)Active
Monograph: Salmeterol
Fluticasone propionateActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform